Thrive Conference Series: Science Supporting PK-Activators and Related Research Update

Описание к видео Thrive Conference Series: Science Supporting PK-Activators and Related Research Update

Dr. Hanny Al-Samkari is a Hematologist/Researcher with Harvard Medical School and Mass General Hospital. He discusses Mitapivat, the first FDA approved PK-Activator for adults developed by Agios Pharmaceuticals as well as developments in research and gene therapy for pyruvate kinase deficiency.

#twpkdnonprofit #pkdeficiency #thrivewithpkd #pyruvatekinasedeficiency #rareanemias #geneticanemia #rareblooddisease #rarehemolyticanemia #pkd #rarebutnotalone #glycolysis #pyruvatekinaseenzyme

@KnowPKDeficiency
@RocketPharma
@ThalassaemiaTIFofficialchannel

Комментарии

Информация по комментариям в разработке

Похожие видео